• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑池型神经囊虫病对杀囊虫药物无反应:病例系列。

Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series.

机构信息

Instituto Nacional de Neurología y Neurocirugía, México DF, México.

出版信息

BMC Neurol. 2010 Mar 4;10:16. doi: 10.1186/1471-2377-10-16.

DOI:10.1186/1471-2377-10-16
PMID:20202200
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2841125/
Abstract

BACKGROUND

Neurocysticercosis (NC) is one of the most frequent parasitic diseases of the central nervous system. Cysticidal drugs, albendazole and praziquantel, are generally effective when parasites localize in the parenchyma. In contrast, parasites lodged in the subarachnoid basal cisterns are less responsive to treatment.

CASE PRESENTATION

The clinical and radiological pictures of six Mexican patients non-respondent to cysticidal treatment are presented.

CONCLUSIONS

The possible factors involved in the cysticidal non-response are discussed and hints are provided of potentially useful changes to therapeutic protocols.

摘要

背景

神经囊虫病(NC)是中枢神经系统最常见的寄生虫病之一。当寄生虫位于实质内时,杀囊虫药物阿苯达唑和吡喹酮通常有效。相比之下,位于蛛网膜下腔基底池的寄生虫对治疗的反应较差。

病例介绍

本文介绍了 6 例墨西哥患者对杀囊虫治疗无反应的临床和影像学图片。

结论

讨论了杀囊虫治疗无反应可能涉及的因素,并提供了治疗方案可能有用的改变提示。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c28/2841125/36590413795a/1471-2377-10-16-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c28/2841125/a80ae763c41c/1471-2377-10-16-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c28/2841125/36590413795a/1471-2377-10-16-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c28/2841125/a80ae763c41c/1471-2377-10-16-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c28/2841125/36590413795a/1471-2377-10-16-2.jpg

相似文献

1
Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series.脑池型神经囊虫病对杀囊虫药物无反应:病例系列。
BMC Neurol. 2010 Mar 4;10:16. doi: 10.1186/1471-2377-10-16.
2
Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.荟萃分析:用于神经囊尾蚴病的杀囊药物:阿苯达唑和吡喹酮。
Ann Intern Med. 2006 Jul 4;145(1):43-51. doi: 10.7326/0003-4819-145-1-200607040-00009.
3
[Giant racemose subarachnoid and intraventricular neurocysticercosis: A case report].[巨大葡萄状蛛网膜下腔和脑室内神经囊尾蚴病:一例报告]
Rev Argent Microbiol. 2015 Jul-Sep;47(3):201-5. doi: 10.1016/j.ram.2015.07.001. Epub 2015 Aug 28.
4
A case from India of neurocysticercosis responsive to albendazole treatment.印度一例对阿苯达唑治疗有反应的神经囊尾蚴病病例。
Parasite. 2000 Mar;7(1):54-6.
5
Parkinsonism associated with neurocysticercosis.与神经囊尾蚴病相关的帕金森综合征
Parkinsonism Relat Disord. 2005 Jan;11(1):69-72. doi: 10.1016/j.parkreldis.2004.07.009. Epub 2004 Dec 8.
6
Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.吡喹酮和阿苯达唑联合抗寄生虫疗法治疗神经囊尾蚴病的疗效:一项双盲随机对照试验。
Lancet Infect Dis. 2014 Aug;14(8):687-695. doi: 10.1016/S1473-3099(14)70779-0. Epub 2014 Jul 3.
7
Primary extensive spinal subarachnoid cysticercosis.原发性广泛脊髓蛛网膜下腔囊尾蚴病。
Spine (Phila Pa 1976). 2012 Sep 1;37(19):E1221-4. doi: 10.1097/BRS.0b013e31825d291e.
8
Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel?神经囊尾蚴病抗蠕虫治疗期间的常规药物与食物相互作用:阿苯达唑和吡喹酮疗效各异的原因?
J Clin Pharmacol. 2014 Apr;54(4):361-7. doi: 10.1002/jcph.269. Epub 2014 Jan 25.
9
Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis.抗蠕虫药物的药代动力学变异性:对神经囊虫病治疗的影响。
Expert Rev Clin Pharmacol. 2012 Jan;5(1):21-30. doi: 10.1586/ecp.11.72.
10
Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle.阿苯达唑和吡喹酮治疗第四脑室神经囊尾蚴病
J Neurosurg. 1997 Jul;87(1):29-33. doi: 10.3171/jns.1997.87.1.0029.

引用本文的文献

1
Obstructive hydrocephalus: when subarachnoid cysts alert to the challenging diagnosis of neurocysticercosis.梗阻性脑积水:当蛛网膜囊肿提示神经囊尾蚴病这一具有挑战性的诊断时。
Quant Imaging Med Surg. 2025 Apr 1;15(4):3759-3764. doi: 10.21037/qims-24-1822. Epub 2025 Mar 25.
2
Murine Extraparenchymal Neurocysticercosis: Appropriate Model for Evaluating Anthelminthic and Anti-Inflammatory Treatment Schedules.小鼠脑外神经囊尾蚴病:评估驱虫和抗炎治疗方案的合适模型。
Trop Med Infect Dis. 2024 Sep 16;9(9):215. doi: 10.3390/tropicalmed9090215.
3
Current Role of Surgery in the Treatment of Neurocysticercosis.

本文引用的文献

1
Changes in beta-giardin sequence of Giardia intestinalis sensitive and resistant to albendazole strains.对阿苯达唑敏感和耐药的肠贾第鞭毛虫β-贾第素序列的变化
Parasitol Res. 2009 Jul;105(1):25-33. doi: 10.1007/s00436-009-1363-7. Epub 2009 Feb 13.
2
Efficacy of albendazole against nematode parasites isolated from a goat farm in Ethiopia: relationship between dose and efficacy in goats.阿苯达唑对从埃塞俄比亚一个山羊养殖场分离出的线虫寄生虫的疗效:山羊用药剂量与疗效之间的关系
Trop Anim Health Prod. 2009 Oct;41(7):1267-73. doi: 10.1007/s11250-009-9311-1. Epub 2009 Feb 5.
3
[Ivermectin as a therapeutic alternative in neurocysticercosis that is resistant to conventional pharmacological treatment].
外科手术在神经囊尾蚴病治疗中的当前作用
Pathogens. 2024 Feb 29;13(3):218. doi: 10.3390/pathogens13030218.
4
Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study.抗寄生虫治疗在坦桑尼亚农村的脑囊虫病的疗效和安全性:一项前瞻性队列研究。
Infection. 2023 Aug;51(4):1127-1139. doi: 10.1007/s15010-023-02021-y. Epub 2023 Mar 24.
5
Subarachnoid racemose neurocysticercosis with cerebellar involvement: an old friend in an infrequent location?脑底池多房性囊尾蚴病伴小脑受累:少见部位的老朋友?
Rev Inst Med Trop Sao Paulo. 2021 Jun 18;63:e43. doi: 10.1590/S1678-9946202163043. eCollection 2021.
6
A Clinical Prognostic Scoring System for Neurocysticercosis.神经囊尾蚴病的临床预后评分系统
J Neurosci Rural Pract. 2021 Jan;12(1):39-45. doi: 10.1055/s-0040-1718845. Epub 2021 Jan 10.
7
Subarachnoid neurocysticercosis: emerging concepts and treatment.蛛网膜下腔神经囊尾蚴病:新出现的概念和治疗方法。
Curr Opin Infect Dis. 2020 Oct;33(5):339-346. doi: 10.1097/QCO.0000000000000669.
8
Natural History of Treated Subarachnoid Neurocysticercosis.治疗性蛛网膜下腔神经囊尾蚴病的自然史。
Am J Trop Med Hyg. 2020 Jan;102(1):78-89. doi: 10.4269/ajtmh.19-0436.
9
Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).神经囊尾蚴病的诊断与治疗:美国传染病学会(IDSA)和美国热带医学与卫生学会(ASTMH)2017年临床实践指南。
Am J Trop Med Hyg. 2018 Apr;98(4):945-966. doi: 10.4269/ajtmh.18-88751.
10
Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).神经囊尾蚴病的诊断与治疗:美国传染病学会(IDSA)和美国热带医学与卫生学会(ASTMH)2017年临床实践指南。
Clin Infect Dis. 2018 Apr 3;66(8):e49-e75. doi: 10.1093/cid/cix1084.
[伊维菌素作为对传统药物治疗耐药的神经囊尾蚴病的一种治疗选择]
Rev Neurol. 2008;46(11):671-4.
4
Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial.阿苯达唑治疗神经囊尾蚴病的效果:一项随机对照试验。
J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1050-5. doi: 10.1136/jnnp.2008.144899. Epub 2008 May 21.
5
Medical treatment for neurocysticercosis: drugs, indications and perspectives.神经囊尾蚴病的医学治疗:药物、适应症及前景
Curr Top Med Chem. 2008;8(5):424-33. doi: 10.2174/156802608783790811.
6
Treatment of cerebral cysticercosis with albendazole in elevated dosages.使用高剂量阿苯达唑治疗脑囊尾蚴病。
Arq Neuropsiquiatr. 2008 Mar;66(1):114-6. doi: 10.1590/s0004-282x2008000100032.
7
Efficacy of nitazoxanide, tizoxanide and tizoxanide/albendazole sulphoxide combination against Taenia crassiceps cysts.硝唑尼特、替唑尼特及替唑尼特/阿苯达唑亚砜组合对肥胖带绦虫囊肿的疗效
J Antimicrob Chemother. 2007 Feb;59(2):212-8. doi: 10.1093/jac/dkl463. Epub 2006 Nov 16.
8
Assessment of anthelmintic resistance in nematode parasites of sheep and goats owned by smallholder farmers in eastern Ethiopia.埃塞俄比亚东部小农户所养绵羊和山羊的线虫寄生虫抗驱虫药情况评估。
Trop Anim Health Prod. 2006 Apr;38(3):215-22. doi: 10.1007/s11250-006-4346-z.
9
Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.荟萃分析:用于神经囊尾蚴病的杀囊药物:阿苯达唑和吡喹酮。
Ann Intern Med. 2006 Jul 4;145(1):43-51. doi: 10.7326/0003-4819-145-1-200607040-00009.
10
Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis.阿苯达唑以每日15或30毫克/千克的剂量用于治疗蛛网膜下腔和脑室内囊尾蚴病的试验。
Neurology. 2006 Feb 14;66(3):436-8. doi: 10.1212/01.wnl.0000195887.63124.dc. Epub 2005 Dec 28.